SP 1001

SP 1001 is a liquid dosage form for oral delivery of cefepime, a fourth generation cephalosporin antibiotic with broad-spectrum activity against both gram positive and gram negative organisms. Cefepime was approved in 1996 and remains widely used, although it has been limited to intravenous administration because no oral form had been available. It is indicated for pneumonia, febrile neutropenia, uncomplicated and complicated urinary tract infections, uncomplicated skin and skin structure infections, and complicated intra-abdominal infections.